Sunday , September 22 2019
Breaking News
Home / Tag Archives: pharma

Tag Archives: pharma

Strides Pharma Science’s arm enters into agreement with SUDA Pharma

Strides Pharma Science’s step-down wholly owned subsidiary — Strides Pharma Global Pte, Singapore has entered into an exclusive product development, licensing and supply agreement with SUDA Pharmaceuticals for its novel drug SUD-001H, an oral spray of sumatriptan to treat migraine headache for the US market. Execution of Strides’ generic product ... Read More »

Glenmark Pharma to launch phase 1 trial in solid tumors for GBR 1342

Glenmark Pharmaceuticals is planning to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342. The decision is driven by recent findings derived from a non-interventional human study utilizing a clinically validated CAN script platform. GBR 1342 is based on Glenmark’s proprietary BEAT platform and ... Read More »

Glenmark Pharma launches Nourkrin in Russia

Glenmark Pharmaceuticals has launched of Nourkrin in Russia. Nourkrin is a globally renowned, clinically-proven proteoglycan replacement formula, for addressing one of the key underlying causes of hair loss in males and females. Nourkrin Woman and Nourkrin Man will be exclusively marketed in Russia by Glenmark Impex LLC, the Russian subsidiary ... Read More »

Sun Pharma comes up with psoriasis treatment drug ‘ILUMYA’ in US

Sun Pharmaceutical Industries has launched its plaque psoriasis treatment drug ‘ILUMYA’ (tildrakizumab-asmn) 100 mg/mL in the United States. ILUMYA is an injectable interleukin-23 (IL-23) inhibitor approved by the USFDA for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. ILUMYA injections are administered ... Read More »

Sun pharma expects to stabilize India business in FY19

Favorable demographics conditions will help the company to ensure reasonable volume growth in India Sun Pharmaceutical Industries is excepting its India business to stabilise in the current fiscal leading to reasonable volume growth since company has witnessing disruptions in 2017-18 due to Goods and Services Tax (GST) implementation. However, favorable ... Read More »

Suresh Prabhu asks pharma companies to invest in R&D

While, speaking at the Organisation of Pharmaceutical Producers of India (OPPI) Summit 2018, Suresh Prabhu urged pharma players to invest in a great amount in research & development. He added that Indian pharma players were facing problem of market access but now that has be resolved after talks with Chinese ... Read More »

Sun Pharma’s arm hikes stake in Ranbaxy Malaysia

Sun Pharmaceutical Industries’ one of the wholly owned subsidiaries has increased its shareholding in Ranbaxy Malaysia, Malaysia, by way of further purchase of 386,865 shares of face value of MYR 1.00 each (equivalent to 4.84%) of Ranbaxy Malaysia. Ranbaxy Malaysia, is a subsidiary of the company, and the total shareholding ... Read More »

Inline

Click & Download Udaipur Kiran App to read Latest News

Inline

Click & Download Udaipur Kiran App to read Latest News